Invention Grant
- Patent Title: Methods and monitoring of treatment with a DLL4 antagonist
-
Application No.: US14068910Application Date: 2013-10-31
-
Publication No.: US09599620B2Publication Date: 2017-03-21
- Inventor: Steven Eugene Benner , Robert Joseph Stagg , Jakob Dupont
- Applicant: ONCOMED PHARMACEUTICALS, INC.
- Applicant Address: US CA Redwood City
- Assignee: ONCOMED PHARMACEUTICALS, INC.
- Current Assignee: ONCOMED PHARMACEUTICALS, INC.
- Current Assignee Address: US CA Redwood City
- Agency: Sterne, Kessler, Goldstein and Fox P.L.L.C.
- Main IPC: G01N33/50
- IPC: G01N33/50 ; A61K39/395 ; C07K16/30 ; G01N33/574 ; G01N33/68 ; A61K31/282 ; A61K31/706 ; G01N33/74 ; A61K31/4045
Abstract:
Methods for treating diseases such as cancer comprising administering a DLL4 antagonist, either alone or in combination with other anti-cancer agents, and monitoring for cardiovascular side effects and/or toxicity.
Public/Granted literature
- US20140220001A1 Methods and Monitoring of Treatment with a DLL4 Antagonist Public/Granted day:2014-08-07
Information query
IPC分类:
